+44 (0) 1865 606333 enquiries@visibleanalytics.co.uk

Our publications

At Visible Analytics, we foster a learning culture, support research initiatives and encourage personal development and professional growth. We pride ourselves on our ever-growing roster of publications disseminating cutting-edge methodologies and applications to a wide range of therapies.

Real World Evidence

Heggie, R., Chappell, F., Crawford, F., Martin, A., Gupta, S., Hawkins, N., Horne, M., Leese, G. P., & Lewsey, J. (2020). Complication rate among people with diabetes at low risk of foot ulceration in Fife, UK: an analysis of routinely collected data. Diabetic medicine: a journal of the British Diabetic Association, 37(12), 2116–2123.

Jenkins, D. A., Hussein, H., Martina, R., Dequen-O’Byrne, P., Abrams, K. R., & Bujkiewicz, S. (2021). Methods for the inclusion of real-world evidence in network meta-analysis. BMC medical research methodology, 21(1), 207.

Torlinska, B., Hazlehurst, J. M., Nirantharakumar, K., Thomas, G. N., Priestley, J. R., Finnikin, S. J., Saunders, P., Abrams, K. R., & Boelaert, K. (2021). wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study. BMJ open, 11(10), e055219.

Teece, L., Gray, L. J., Melbourne, C., Orton, C., Ford, D. V., Martin, C. A., McAllister, D., Khunti, K., Tobin, M., John, C., Abrams, K. R., Pareek, M., & UK-REACH Study Collaborative Group (2021). United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): a retrospective cohort study using linked routinely collected data, study protocol. BMJ open, 11(6), e046392.

Strategic HTA support

Bouttell, J., Briggs, A., & Hawkins, N. (2020). A different animal? Identifying the features of health technology assessment for developers of medical technologies. International journal of technology assessment in health care, 1–7. Advance online publication.

Bouttell, J., Briggs, A., & Hawkins, N. (2021). The thorny issue of value alignment: how development-focused health technology assessment can help find win-win situations for patients and healthcare systems and commercial investors. International journal of technology assessment in health care, 37(1), e57.

Statistical Analysis

Hawkins, N., Muszbek, N., Evans, R., Dequen-O’Byrne, P., Jones, T., & McNamara, L. (2022). Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome. Journal of comparative effectiveness research, 11(11), 805–813.

Freeman, S. C., Cooper, N. J., Sutton, A. J., Crowther, M. J., Carpenter, J. R., & Hawkins, N. (2022). Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network. Statistical methods in medical research, 31(5), 839–861.

Evans, R., Hawkins, N., Dequen-O’Byrne, P., McCrea, C., Muston, D., Gresty, C., Ghate, S. R., Fan, L., Hettle, R., Abrams, K. R., de Bono, J., Hussain, M., & Agarwal, N. (2021). Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC). Targeted oncology, 16(5), 613–623.

Evidence Synthesis

Thompson, J. C., Mahajan, A., Scott, D. A., & Gairy, K. (2022). The Economic Burden of Lupus Nephritis: A Systematic Literature Review. Rheumatology and therapy, 9(1), 25–47.

Thompson, J. C., Chalet, F. X., Manalastas, E. J., Hawkins, N., Sarri, G., & Talbot, D. A. (2022). Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review. Neurology and therapy, 11(2), 597–620.

Singh, J., Gsteiger, S., Wheaton, L., Riley, R. D., Abrams, K. R., Gillies, C. L., & Bujkiewicz, S. (2022). Bayesian network meta-analysis methods for combining individual participant data and aggregate data from single arm trials and randomised controlled trials. BMC medical research methodology, 22(1), 186.

Owen, R. K., Bujkiewicz, S., Tincello, D. G., & Abrams, K. R. (2020). Multivariate network meta-analysis incorporating class effects. BMC medical research methodology, 20(1), 184.

Hannigan, L. J., Phillippo, D. M., Hanlon, P., Moss, L., Butterly, E. W., Hawkins, N., Dias, S., Welton, N. J., & McAllister, D. A. (2022). Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study. Medical decision making: an international journal of the Society for Medical Decision Making, 42(2), 228–240.

Smith, E. A., Cooper, N. J., Sutton, A. J., Abrams, K. R., & Hubbard, S. J. (2021). A review of the quantitative effectiveness evidence synthesis methods used in public health intervention guidelines. BMC public health, 21(1), 278.

Papanikos, T., Thompson, J. R., Abrams, K. R., & Bujkiewicz, S. (2022). Use of copula to model within-study association in bivariate meta-analysis of binomial data at the aggregate level: A Bayesian approach and application to surrogate endpoint evaluation. Statistics in medicine, 41(25), 4961–4981.

Bujkiewicz, S., Singh, J., Wheaton, L., Jenkins, D., Martina, R., Hyrich, K. L., & Abrams, K. R. (2022). Bridging disconnected networks of first and second lines of biologic therapies in rheumatoid arthritis with registry data: bayesian evidence synthesis with target trial emulation. Journal of clinical epidemiology, 150, 171–178. Advance online publication.

Ribero, V. A., Daigl, M., Martí, Y., Gorni, K., Evans, R., Scott, D. A., Mahajan, A., Abrams, K. R., & Hawkins, N. (2022). How does risdiplam compare with other treatments for Types 1-3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison. Journal of comparative effectiveness research, 11(5), 347–370.

Garcia Sanchez, J. J., Thompson, J., Scott, D. A., Evans, R., Rao, N., Sörstadius, E., James, G., Nolan, S., Wittbrodt, E. T., Abdul Sultan, A., Stefansson, B. V., Jackson, D., & Abrams, K. R. (2022). Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials. Advances in Therapy, 39(1), 193-220.

Economic Modelling

Muszbek, N., Remak, E., Evans, R., Brennan, V. K., Colaone, F., Shergill, S., Mullan, D., & Ross, P. J. (2021). Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma. Future oncology (London, England), 17(9), 1055–1068.

Muszbek, N., Evans, R., Remak, E., Brennan, V. K., Colaone, F., Shergill, S., Ross, P., & Mullan, D. (2022). Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC). Expert review of pharmacoeconomics & outcomes research, 22(1), 147–154.